Form 4 holding
SVP and General Counsel
MADRIGAL PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 17,691
- Estimated value
- $4,315,189
- Report date
- 23 Jan 2024
- Price
- $243.92
- Ownership
- Direct
Brian J. Lynch - SVP and General Counsel at MADRIGAL PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- SVP and General Counsel
- Issuer ticker
- MDGL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Brian J. Lynch since 22 Aug 2025
Reported holdings for Brian J. Lynch in MADRIGAL PHARMACEUTICALS, INC.
Form 4 holding
SVP and General Counsel
MADRIGAL PHARMACEUTICALS, INC.
- Security class
- Market Stock Unit
- Shares / value
- 3,639
- Estimated value
- $887,625
- Report date
- 23 Jan 2024
- Price
- $243.92
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP and General Counsel
MADRIGAL PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 530
- Estimated value
- $129,278
- Report date
- 23 Jan 2024
- Price
- $243.92
- Ownership
- In IRA
Form 4 holding
SVP and General Counsel
MADRIGAL PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 5,483
- Estimated value
- Report date
- 23 Jan 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Brian J. Lynch in MADRIGAL PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.